Literature DB >> 23855295

Tumor microenviroment and hepatocellular carcinoma metastasis.

Hongyang Wang1, Lei Chen.   

Abstract

The cross talk between tumor cells and the surrounding peritumoral stroma has been extensively studied as a dynamic system involving the processes of hepatocarcinogenesis, tumor invasion, and metastasis in recent few decades. Besides hepatocytes, liver tumor microenvironments are generally classified into cellular and noncellular components, including hepatic stellate cells, fibroblasts, immune, endothelial, mesenchymal stem cells, together with growth factors, cytokines, extracellular matrix, hormone as well as viruses et al. The noncellular components manipulate hepatocellular carcinoma invasion and metastasis by facilitating epithelial-mesenchymal transition, increasing proteolytic activity of matrix metalloproteinases, and regulating antitumor immunity, etc. Because the main cause of death in hepatocellular carcinoma patients is tumor progression with metastasis, a better understanding of the interplay between hepatocytes and their environment during tumor metastasis may be helpful for the discovery of novel molecular targets.
© 2013 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  hepatocellular carcinoma; tumor metastasis; tumor microenviroment

Mesh:

Substances:

Year:  2013        PMID: 23855295     DOI: 10.1111/jgh.12091

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  47 in total

Review 1.  New knowledge of the mechanisms of sorafenib resistance in liver cancer.

Authors:  Yan-Jing Zhu; Bo Zheng; Hong-Yang Wang; Lei Chen
Journal:  Acta Pharmacol Sin       Date:  2017-03-27       Impact factor: 6.150

2.  Ammonium chloride inhibits autophagy of hepatocellular carcinoma cells through SMAD2 signaling.

Authors:  Ranran Sun; Yonggang Luo; Juan Li; Qiongye Wang; Jingjing Li; Xiaolong Chen; Kelei Guan; Zujiang Yu
Journal:  Tumour Biol       Date:  2014-10-24

3.  Niclosamide suppresses migration of hepatocellular carcinoma cells and downregulates matrix metalloproteinase-9 expression.

Authors:  Minoru Tomizawa; Fuminobu Shinozaki; Yasufumi Motoyoshi; Takao Sugiyama; Shigenori Yamamoto; Naoki Ishige
Journal:  Oncol Lett       Date:  2015-10-09       Impact factor: 2.967

4.  MiR-570 inhibited the cell proliferation and invasion through directly targeting B7-H1 in hepatocellular carcinoma.

Authors:  Wei Guo; Wei Tan; Shan Liu; Xuhui Huang; Juze Lin; Ronghua Liang; Le Su; Qiao Su; Changjun Wang
Journal:  Tumour Biol       Date:  2015-06-18

5.  Exogenous hydrogen sulfide promotes hepatocellular carcinoma cell growth by activating the STAT3-COX-2 signaling pathway.

Authors:  Yulan Zhen; Qiaomei Wu; Yiqian Ding; Wei Zhang; Yuansheng Zhai; Xiaoxiong Lin; Yunxia Weng; Ruixian Guo; Ying Zhang; Jianqiang Feng; Yiyan Lei; Jingfu Chen
Journal:  Oncol Lett       Date:  2018-03-02       Impact factor: 2.967

6.  Inhibition of fibroblast growth factor receptor signaling impairs metastasis of hepatocellular carcinoma.

Authors:  Jiajun Wang; Hongying Su; Xiangjun Han; Ke Xu
Journal:  Tumour Biol       Date:  2014-08-05

7.  microRNAs carried by exosomes promote epithelial-mesenchymal transition and metastasis of liver cancer cells.

Authors:  Qin-Lian Chen; Chun-Feng Xie; Kun-Liang Feng; Dong-Ying Cui; Shui-Lian Sun; Jun-Chang Zhang; Cheng-Ming Xiong; Jun-Hai Huang; Zhong Chong
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

8.  Overexpression of long non-coding RNA cancer susceptibility 11 is involved in the development of chemoresistance to carboplatin in hepatocellular carcinoma.

Authors:  Haidong Liu; Tao Liu; Yong Zhou; Xinwen Song; Rendong Wei
Journal:  Oncol Lett       Date:  2020-01-08       Impact factor: 2.967

9.  Th22 cells are associated with hepatocellular carcinoma development and progression.

Authors:  Shanyu Qin; Shijia Ma; Xiaoli Huang; Donghong Lu; You Zhou; Haixing Jiang
Journal:  Chin J Cancer Res       Date:  2014-04       Impact factor: 5.087

Review 10.  NK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinoma.

Authors:  Cheng Sun; Haoyu Sun; Cai Zhang; Zhigang Tian
Journal:  Cell Mol Immunol       Date:  2014-10-13       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.